Scarica l'app Stockscreener
27.44
1.65%
-0.46
Dopo l'orario di chiusura:
27.52
0.08
+0.29%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$27.90
Aprire:
$27.3
Volume 24 ore:
7.54M
Relative Volume:
0.52
Capitalizzazione di mercato:
$6.40B
Reddito:
$2.35B
Utile/perdita netta:
$128.37M
Rapporto P/E:
52.56
EPS:
0.5221
Flusso di cassa netto:
$57.42M
1 W Prestazione:
-1.37%
1M Prestazione:
-13.63%
6M Prestazione:
+16.92%
1 anno Prestazione:
-42.57%
Intervallo 1D:
$27.12
$28.00
Intervallo di 1 settimana:
$27.12
$28.33
Portata 52W:
$13.74
$65.30
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
27.44 | 6.51B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 58.15B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.35 | 42.94B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.59B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.86 | 30.29B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.86 | 21.74B | 3.17B | 1.29B | 1.01B | 27.09 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-24 | Iniziato | JP Morgan | Overweight |
| 2026-03-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2026-03-10 | Aggiornamento | Citigroup | Sell → Neutral |
| 2026-03-09 | Aggiornamento | Needham | Hold → Buy |
| 2026-02-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2026-01-12 | Iniziato | Evercore ISI | In-line |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-21 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Downgrade | Needham | Buy → Hold |
| 2025-06-04 | Reiterato | Needham | Buy |
| 2025-04-29 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - The Daily Tribune News
Hims & Hers Health, Inc. (HIMS) Stock Price & News - Syfe
Hims & Hers Health, Inc. (HIMS) Class Action Lawsuit Seeks - globenewswire.com
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Hims & - globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, - GlobeNewswire
Kaplan Fox Continues to Remind Hims & Hers Health, Inc. (NYSE: HIMS) Investors of the Lead Plaintiff Deadline on November 2, 2026 - NewMediaWire
Faruqi & Faruqi, LLP Urges Hims & Hers Health, Inc. (HIMS) Invest - The National Law Review
HIMS & HERS HEALTH, INC. INVESTORS WITH LOSSES HAVE UNTIL - globenewswire.com
Portnoy Law Firm Announces Class Action on Behalf of Hims & Hers Health, Inc. Investors - globenewswire.com
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 2, 2026 Against Hims & Hers Health, Inc. (NYSE: HIMS) - newmediawire.com
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds - globenewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Reach Out - ACCESS Newswire
Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit Before November 2, 2026 Deadline - PR Newswire
Deadline Alert: Hims & Hers Health, Inc. (HIMS) - globenewswire.com
Hims & Hers Health, Inc. • Robinhood Token (HIMS) Preț Azi - Bybit
HIMS Class Action Reminder – Robbins LLP Reminds Investors - globenewswire.com
Why Is Hims & Hers Health (HIMS) Down 7.7% Since Last Earnings Report? - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Regulatory Scrutiny and AI Potential - Quiver Quantitative
Hims & Hers Health, Inc. • Robinhood Token (HIMS) Price Prediction for 2026 to 2031 - Bybit
Is FTC Lawsuit Altering The Investment Case For Hims Stock (HIMS)? - simplywall.st
Kaplan Fox Continues to Alert Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Class Action Deadline on November 2, 2026 - NewMediaWire
Hims & Hers Health, Inc. Securities Fraud Class Action - globenewswire.com
Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know - Yahoo Finance
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors Seeking Recovery to Contact the Firm Before November 2, 2026 - NewMediaWire
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount - Investing.com Canada
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Kaplan Fox Encourages Wix.com Ltd. (NASDAQ: WIX) Investors with Significant Losses to Contact the Firm Before September 22, 2026 - GlobeNewswire Inc.
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law - globenewswire.com
HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS - PR Newswire
Here's Why Teladoc's Integrated Care Business Deserves More Attention - TradingView
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Investors to Learn More About the Investigation | NYSE:HIMS | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - PR Newswire
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Inves - The National Law Review
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investo - GuruFocus
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
HIMS Stock Kicks Off September In The Red: FDA’s GLP-1 Alert Steals The Spotlight From Australia Expansion - Stocktwits
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc.HIMS - PR Newswire
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026 - NewMediaWire
ROSEN, LEADING TRIAL COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - ACCESS Newswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Hims & Hers - GlobeNewswire
DEADLINE ALERT for YSS, HIMS, and UNCY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - WBOC TV
Hims & Hers stock price is surging today. A surprising deal with Novo Nordisk is the reason why - Fast Company
Investor relations - HIMS investor relations
FTC Hims and Hers Lawsuit: What the Telehealth Giant Didn't Want You to Know About Your Health Data - lawnews.co.uk
Hims & Hers Health, Inc. Securities Fraud Class Action Result of - The National Law Review
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before Lead Plaintiff Deadline on November 2, 2026 - NewMediaWire
Is Hims & Hers Health Inc (HIMS) a Bargain After 3.0% Drop? GF V - GuruFocus
Hims & Hers Health shares fall over 3% as sellers reinforce pressure and technical weakness persists - Traders Union
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):